Genetic instability and fanconi anemia

Chromosomal Instability and Aging: Basic Science and Clinical Implications

Volumn , Issue , 2003, Pages 375-408

  Hoehn, Holger ^a   Gross, Michaela Thiel ^a   Schindler, Detlev ^a   Sobeck, Alexandra ^b   Wagner, Matthias ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c LYNKEUS BioTech GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 13944250151     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (161)

1. G Fanconi. Familiäre infantile perniziosaartige Anämie. Jahrb Kinderh 117: 257-280, 1927.
2. PF Giampetro, B Adler-Becher, PC Verlander, SG Pavlakis, JG Davis, AA Auerbach. The need for more accurate and timely diagnosis in Fanconi anemia: a report from the International Fanconi Anemia Registry. Pediatrics 91:1116-1120, 1993
3. AP Gillio, PC Verlander, SD Batish, PF Giampetro, AD Auerbach. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: in International Fanconi Anemia Registry study. Blood 90:105-110, 1997.
4. GM Martin, J Oshima. Lessons from the human progeroid syndromes. Nature 408:263-266, 2000.
5. MP Wajnrajch, JM Gertner, Z Huma, J Popvic, K Lin, PC Verlander, SD Batish, PF Giampetro, JG Davis, MI New, AD Auerbach. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatics 107:744-754, 2001.
6. BP Alter, CL Frissora, DS Halperin, FH Freedman, U Chitkara, E Alvarez, L Lynch, B Adler-Brecher, AD Auerbach. Fanconi's anaemia and pregnancy. Br J Haematol 77:410-418, 1991.
7. BP Auerbach. Fanconi's anemia and malignancies. Am J Hematol 53:99-110, 1996.
8. JC Schultz, NT Shahidi. Tumor necrosis factor-alpha overproduction in Fanconi's anemia. Am J Hematol 42:196-201, 1993.
9. F Roselli, J Sanceau, E Gluckman, J Wietzerbin, E Moustacchi. Abnormal lym-phokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood 83:1216-25, 1994.
10. RK Rathbun, TA Christianson, GR Faulkner, G Jones, W Keeble, M O’Dwyer, G Bagby. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood 96:4204-4211, 2000.
11. B Cassinat, P Guardiola, S Chevret, MH Schlageter, ME Toubert, JD Rain, E Gluck-man. Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia. Blood 96:859-863, 2000.
12. GM Segal, RE Magenis, M Brown, W Keeble, TD Smith, MC Heinrich, GC Bagby Jr. Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest 94:846-852, 1994.
13. RK Rathbun, GR Faulkner, MH Ostroski, TA Christianson, G Hughes, G Jones, R Cahn, R Maziarz, G Royle, W Keeble, MC Heinrich, M Grompe, PA Tower, GC Bagby. Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells. Blood 90:974-985, 1997.
14. LS Haneline, TA Gobett, R Ramani, M Carreau, M Buchwald, MC Yoder, DW Clapp. Loss of FancC function results in decreased hematopoietic stem cell repopulation ability. Blood 94:1-8, 1999.
15. KP Bataille, RL Bateman, D Mortimer, J Mulcahy, RK Rathbun, G Bagby, WH Fleming, M Grompe. In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. Blood 94:2151-2158, 1999.
16. NC Cheng, HJ van de Vrugt, MA van der Valk, AB Oostra, P Krimenfort, Y de Vries, H Joenje, A Berns, F Arwert. Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet 9:1805-1811, 2000.
17. S Zakrewski, K Sperling. Genetic heterogeneity of Fanconi's anemia demonstrated by somatic cell hybrids. Hum Genet 56:81-84, 1980.
18. CA Strathdee, AMW Duncan, M Buchwald. Evidence for at least four Fanconi anemia genes including FACC on chromosome 9. Nat Genet 1:196-200, 1992.
19. H Joenje, JR Lo ten Foe, AB Oostra, CGM van Berkel, MA Rooimans, T Schroeder-Kurth, RD Wegner. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood 86:2156-2160, 1995.
20. H Joenje, AB Oostra, M Wijker, FM die Summa, CGM van Berkel, MA Rooimans, W Ebell, M van Weel, JC Pronk, M Buchwald, F Arwert. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 61:940-944, 1997.
21. H Joenje, AB Oostra, MA Rooimans, M van Weel, JC Pronk, F Arwert. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet 67:759-762, 2000.
22. T Yamashita, N Wu, G Kupfer, C Corless, H Joenje, M Grompe, AD D’Andrea. The clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated FAC polypeptide with partial activity. Blood 87:4424-4429, 1996.
23. M Futaki, T Yamashita, H Yagasaki, T Toda, M Yabe, S Kato, S Asano, T Naka-hata. The IVS4+4 A to T mutation of the Fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood 95:1493-1498, 2000.
24. AP Gillio, P Verlander, SD Batish, BF Giampetro, AD Auerbach. Phenotypic consequences of mutations in the Fanconi anemia FANCC gene: an International Fanconi Anemia Registry study. Blood 90:105-110, 1997.
25. L Faivre, P Guardiola, C Lewis, I Dokal, W Ebell, A Zatterale, C Altay, J Poole, D Stones, ML Kwee, M van Weel-Sipman, C Havenga, N Morgan, J de Winter, M Dig-weed, A Savoia, J Pronk, T de Ravel, S Jansen, H Joenje, E Gluckman, CG Mathew. Association of complementation group and mutation type with clinical outcome in Fanconi anemia. European Fanconi Anemia Research Group. Blood 96:4064-4070, 2000.
26. H Joenje, KJ Patel. The emerging genetic and molecular basis of Fanconi anemia. Nat Rev Genet 2:446-459, 2001.
27. I Nanda, Z Shan, M Schartl, DW Burt, M Koehler, H Nothwang, F Grutzner, IR Pa-ton, D Windsor, I Dunn, W Engel, P Staeheli, S Mizuno, T Haaf, M Schmid. 300 million years of conserved synteny between chicken Z and human chromosome 9. Nat Genet 21:258-259, 1999.
28. M Chen, DJ Tomkins, W Auerbach, C McKerlie, H Youssoufian, L Liu, O Gan, M Carreau, A Auerbach, T Groves, CJ Guidos, MH Freedman, J Cross, DH Percy, JE Dick, AL Joyner, M Buchwald. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat Genet 12:448-451, 1996.
29. JJ Nadler, RE Braun. Fanconi anemia complementation group C is required for proliferation of murine primordial germ cells. Genesis 27:117-123, 2000.
30. HJ van de Vrugt, NC Cheng, Y de Vries, MA Rooimans, J de Groot, RJ Scheper, Y Zhi, ME Hoatlin, H Joenje, F Arwert. Cloning and characterization of murine Fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis and ovary. Mamm Genome 11:326-331, 2000.
31. I Garcia-Higuera, T Taniguchi, S Ganesan, MS Meyn, C Timmers, J Hejna, M Grompe, AD D’Andrea. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7:249-262, 2001.
32. L Dailey, C Basilico. Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes. J Cell Physiol 186:315-328, 2001.
33. W Liebetrau, M Buhner, H Hoehn. Prototype sequence clues in the FAC gene. J Med Genet 32:669-670, 1995.
34. JR Lo Ten Foe, MA Rooimans, L Bosnoyan-Collins, N Alon, M Wijker, L Parker, J Lightfoot, M Carreau, DF Callen, A Savoia, NC Cheng, CG van Berkel, MH Strunk, JJ Gille, G Pals, FA Kruyt, JC Pronk, F Arwert, M Buchwald, H Joenje. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet 14:320-323, 1996.
35. M Futaki, S Watanabe, S Kajigaya, JM Liu. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment. Biochem Biophys Res Commun 281:347-351, 2001.
36. T Yamashita, GM Kupfer, D Naf, A Suliman, H Joenje, AD Asonao D’Andrea. The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc Natl Acad Sci USA 95:13085-13090, 1998.
37. W Liebetrau, A Budde, A Savoia, F Grummt, H Hoehn. p53 activates Fanconi anemia group C gene expression. Hum Mol Genet 6:277-283, 1997.
38. F Krasnoshtein, M Buchwald. Developmental expression of the Fac gene correlates with congenital defects in Fanconi anemia patients. Hum Mol Genet 5:85-93, 1996.
39. GM Kupfer, D Naf, A Suliman, M Pulsipher, AD D’Andrea. The Fanconi anemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet 17:487-490, 1997.
40. I Garcia-Higuera, Y Kuang, J Denham, AD D’Andrea. The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex. Blood 96:3224-3230, 2000.
41. Q Waisfisz, JP de Winter, FA Kruyt, J de Groot, L van der Weel, LM Dijkmans, Y Zhi, F Arwert, RJ Scheper, H Youssoufian, ME Hoatlin, H Joenje. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci USA 96:10320-10325, 1999
42. JP de Winter, L van der Weel, J de Groot, S Stone, Q Waisfisz, F Arwert, RJ Scheper, FA Kruyt, ME Hoatlin, H Joenje. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet 9:2665-2674, 2000.
43. ME Hoatlin, TA Christianson, WW Keeble, AT Hammond, Y Zhi, MC Heinrich, PA Tower, CG Bagby Jr. The Fanconi anemia group C gene product is located in both the nucleus and the cytoplasm of human cells. Blood 91:1418-1425, 1998.
44. M Buchwald, E Moustacchi. Is Fanconi anemia caused by a defect in the processing of DNA damage? Mutat Res 408:75-90, 1998.
45. M Escarceller, M Buchwald, BK Singleton, PA Jeggo, SP Jackson, E Moustacchi, D Papadopoulo. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining. J Mol Biol 279:375-385, 1998.
46. KR Kumaresan, MW Lambert. Fanconi anemia, complementation group A cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links. Carcinogenesis 21:741-751, 2000.
47. JP De Winter, Q Waisfisz, MA Rooimans, CGM van Berkel, L Bosnoyan-Collins, N Alon, M Carreau, O Bender, I Demuth, D Schindler, JC Pronk, F Arwert, H Hoehn, M Digweed, M Buchwald, H Joenje. The Fanconi group G gene FANCG is identical with XRCC9. Nat Genet 20:282-283, 1998.
48. C Timmers, T Taniguchi, J Hejna, C Reifsteck, L Lucas, D’ Bruun, M Thayer, B Cox, S Olson, AD D’Andrea, R Moses, M Grompe. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell 7:241-248, 2001.
49. FAE Kruyt, T Hoshino, JM Liu, P Joseph, AK Jaiswal, H Youssoufian. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 92:3050-3056, 1998.
50. MC Heinrich, KV Silvey, S Stone, AJ Zigler, DJ Griffith, M Montalto, L Chai, Y Zhi, ME Hoatlin. Post-transcriptional cell cycle-dependent regulation of human FANCC expression. Blood 95:3970-3977, 2000.
51. H Youssoufian. Cytoplasmic localization of FAC is essential for the correction of a prerepair defect in Fanconi anemia group C cells. J Clin Invest 97:2003-2010, 1996.
52. T Reuter, S Herterich, O Bernhard, H Hoehn, HJ Gross. Strong FANCA/FANCG but weak FANCA/FANCC interaction in the yeast two hybrid system. Blood 95:719-720, 2000.
53. AL Medhurst, PA Huber, Q Waisfisz, JP de Winter, CG Mathew. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum Mol Genet 10:423-429, 2001.
54. TM Schroeder-Kurth, AD Auerbach, G Obe, eds. Fanconi Anemia. Clinical, Cytogenetic and Experimental Aspects. Berlin: Springer-Verlag, 1989.
55. K Motejlek, D Schindler, G Assum, W Krone. Increased amount and contour length distribution of small polydisperse circular DNA (spcDNA) in Fanconi anemia. Mut Res DNA Repair 293:205-214, 1993.
56. LH Thompson, D Schild. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat Res 477:131-153, 2001.
57. MW Lambert, GJ Tsongalis, WC Lambert, B Hang, DD Parrish. Defective DNA endonuclease activities in Fanconi's anemia cells, complementation groups A and B. Mutat Res 273:57-71, 1992.
58. A Laquerbe, E Moustacchi, JC Fuscoe, D Papdopoulo. The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination. Proc Natl Acad Sci USA 92:831-885, 1995.
59. D Averbeck, D Papadopoulo, E Moustacchi. Repair of 4,5‘8-trimethylpsoralen plus light-induced DNA damage in normal and Fanconi's anemia cell lines. Cancer Res 48:2015-2020, 1988.
60. J Smith, JC Andrau, S Kallenbach, A Laguerbe, N Doyen, D Papadopoulo. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. J Mol Biol 281:815-825, 1998.
61. R Lundberg, M Mavinakere, C Campell. Deficient DNA end joining activity in extracts from Fanconi anemia fibroblasts. J Biol Chem 279:9543-9549, 2001.
62. JP Carney, RS Maser, H Olivares, EM Davis, M Le Beau, JR Yates 3rd, L Hays, WF Morgan, JH Petrini. The hMre11/Rad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477-486, 1998.
63. E Raderschall, EI Golub, T Haaf. Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proc Natl Acad Sci USA 96:1921-1926, 1999.
64. S Tashiro, J Walter, A Shinohara, N Kamada, T Cremer. Rad51 accumulation at sites of DNA damage in postreplicative chromatin. J Cell Biol 150:283-291, 2000.
65. Y Liu, N Maizels. Coordinated response of mammalian Rad51 and Rad52 to DNA damage. EMBO Rep 1:85-90, 2000.
66. M Takata, MS Sasaki, S Tachiiri, T Fukushima, E Sonoda, D Schild, LH Thompson, S Takeda. Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol 21:2858-2866, 2001.
67. RC Cumming, JM Liu, H Youssoufian, M Buchwald. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene. Blood 88:4558-4567, 1996.
68. A Ridet, C Guillof, E Duchaud, E Cundari, M Fiore, E Moustacchi, F Rosselli. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome. Cancer Res 57:1722-1730, 1997.
69. C Guillof, TS Wang, J Liu, CE Walsh, GG Poirier, E Moustacchi, F Rosselli. Fanconi anemia C protein acts as switch between apoptosis and necrosis in mitomycin C-induced cell death. Exp Cell Res 246:384-394, 1999.
70. T Haaf, E Raderschall, G Reddy, DC Ward, CM Radding, EI Golub. Sequestration of mammalian Rad51-recombination protein into micronuclei. J Cell Biol 144:11-20, 1999.
71. KW Kinzler, B Vogelstein. Gatekeepers and caretakers. Nature 386:761-763, 1997.
72. TM Schroeder, F Anschutz, A Knopp. Spontane Chromosomenaberrationen bei fa-miliarer Panmyelopathie. Humangenetik 1:194-196, 1964.
73. AD Auerbach. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol 21:731-733, 1993.
74. M Carreau, N Alon, L Bosnoyan-Collins, H Joenje, M Buchwald. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat Res 435:103-109, 1999.
75. CS Djuzenova, A Rothfuss, U Oppitz, G Speit, D Schindler, H Hoehn, M Flentje. Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab Invest 81:185-192, 2001.
76. T Reuter, S Herterich, H Hoehn, HJ Gross. Search for proteins involved in the pathogenesis of Fanconi anemia. Am J Hum Genet 61:A181, 1997.
77. T Reuter. Die Fanconi Proteine: Ein Beitrag zur Aufklärung ihrer Funktion. PhD dissertation, University of Wuerzburg, Wuerzburg, Germany, 2000.
78. TT Paull, EP Rogakou, V Yamazaki, CU Kirchgessner, M Gellert, WM Bonner. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10:886-895, 2000.
79. JR Davie, M Moniwa. Control of chromatin remodeling. Crit Rev Eukaryot Gene Expr 10:303-325, 2000.
80. DA Bochar, L Wang, H Beniya, A Kinev, Y Xue, WS Lane, W Wang, F Kashanchi, R Shiekhattar. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102:257-265, 2000.
81. ME Hoatlin, Y Zhi, H Ball, K Silvey, A Melnick, S Stone, S Arai, N Hawe, G Owen, A Zelent, JD Licht. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF. Blood 94:3737-3747, 1999.
82. PH Gaillard, EM Martini, PD Kaufman, B Stillman, E Moustacchi, G Almouzni. Chromatin assembly coupled to DNA repair: a new role for chromatin assembly factor I. Cell 86:887-896, 1996.
83. F Qiao, A Moss, GM Kupfer. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage and cell cycle-regulated manner. J Biol Chem 276:23391-23396, 2001.
84. Y Xie, JP de Winter, Q Waisfisz, AW Nieuweint, RJ Scheper, F Arwert, ME Hoatlin, GJ Ossenkoppele, GJ Schuurhuis, H Joenje. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells. Br J Haematol 111:1057-1064, 2000.
85. JR Lo Ten Foe, ML Kwee, MA Rooimans, AB Oostra, AJP Veerman, M van Weel, RM Pauli, NT Shahidi, I Dokal, I Roberts, C Altay, E Gluckman, RA Gibson, CG Mathew, F Arwert, H Joenje. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet 5:137-148, 1997.
86. H Joenje, F Arwert, ML Kwee, K Madan, H Hoehn. Confounding factors in the diagnosis of Fanconi anaemia. Am J Med Genet 79:403-405, 1998.
87. JJ Gregory Jr, JE Wagner, PC Verlander, O Levran, SD Batish, CR Eide, A Steffenhagen, B Hirsch, AD Auerbach. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc Natl Acad Sci USA 98:2532-2537, 2001.
88. O Levran, T Erlich, N Magdalena, J Gregory, S Batish, P Verlander, A Auerbach. Sequence variation in the Fanconi anemia gene FAA. Proc Natl Acad Sci USA 94:13051-13056, 1997.
89. NV Morgan, AJ Tipping, H Joenje, CG Mathew. High frequency of large intragenic deletions in the Fanconi group A gene. Am J Hum Genet 65:1330-1341, 1999.
90. Q Waisfisz, NV Morgan, M Savino, JP de Winter, CG van Berkel, ME Hoatlin, L Ianzano, RA Gibson, F Arwert, A Savoia, CG Mathew, JC Pronk, H Joenje. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet 22:379-383, 1999.
91. R Berger, P Jonveaux. Clonal chromosome abnormalities in Fanconi anemia. Hema-tol Cell Ther 38:291-296, 1996.
92. BP Alter, A Scalise, J McCombs, V Najfeld. Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean? Br J Haematol 85:627-630, 1993.
93. BP Alter, JP Caruso, RA Drachtman, T Uchida, GV Velagaleti, MT Elghetany. Fanconi anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 117:125-131, 2000.
94. MT Smith, L Zhang, M Jeng, Y Wang, W Guo, P Duramad, AE Hubbard, G Hofstadler, NT Holland. Hydrochinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Carcinogenesis 21:1485-1490, 2000.
95. TA McDonald, NT Holland, C Skibola, P Duramad, MT Smith. Hypothesis: phenol and hydroquinone derived mainly from diet and gastrointestinal flora activity are causal factors in leukemia. Leukemia 15:10-20, 2001.
96. F Leteutre, X Li, P Guardiola, G Le Roux, JC Sergere, P Richard, ED Carosella, E Gluckman. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol 105:883-893, 1999.
97. SE Ball, FM Gibson, S Rizzo, JA Tooze, JC Marsh, EC Gordon-Smith. Progressive telomere shortening in aplastic anemia. Blood 91:3582-3592, 1998.
98. GM Martin, CA Sprague, TH Norwood, WR Pendergrass. Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. Am J Pathol 74:137-154, 1974.
99. C Lengauer, KW Kinzler, B Vogelstein. Genetic instabilities in human cancers. Nature 396:643-649, 1998.
100. M Lensch, R Rathbun, S Olson, GR Jones, GC Bagby Jr. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia. Leukemia 13:1784-1789, 1999
101. E Elmore, M Swift. Growth of cultured cells from patients with Fanconi anemia. J Cell Physiol 87:229-233, 1975.
102. R Weksberg, M Buchwald, P Sargent, MW Thompson, L Siminovitch. Specific cellular defects in patients with Fanconi anemia. J Cell Physiol 101:311-323, 1979.
103. B Dutrillaux, A Aurias, AM Dutrillaux, D Buriot, M Prieur. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 62:327-332, 1982.
104. M Kubbies, D Schindler, H Hoehn, A Schinzel, PS Rabinovitch. Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent endomitosis in Fanconi anemia cells. Am J Hum Genet 37:1022-1030, 1985.
105. R Berger, M Le Coniat, MC Gendron. Fanconi anemia. Chromosome breakage and cell cycle studies. Cancer Genet Cytogenet 69:13-16, 1993.
106. H Seyschab, R Friedl, Y Sun, D Schindler, H Hoehn, S Hentze, T Schroeder-Kurth. Comparative evaluation of diepoxybutane sensitivity and cell cycle blockage in the diagnosis of Fanconi anemia. Blood 85:2233-2237, 1995.
107. FA Kruyt, LM Dijkmans, F Arwert, H Joenje. Involvement of the Fanconi’s anemia protein FAC in a pathway that signals to the cyclin B/cdc2 kinase. Cancer Res 57:2244-2251, 1997.
108. GM Kupfer, T Yamashita, D Naf, A Suliman, S Asano, AD D’Andrea. The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase cdc2. Blood 90:1047-1054, 1997.
109. SA Centurion, HR Kuo, WC Lambert. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp Cell Res 260:216-221, 2000.
110. M Sala-Trepat, D Rouillard, M Escarceller, A Laquerbe, E Moustacchi, D Pa-padopoulo. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp Cell Res 260:208-215, 2000
111. L Sabatier, B Dutrillaux. Effect of caffeine in Fanconi anemia. I. Restoration of a normal duration of G2 phase. Hum Genet 79:242-244, 1988.
112. H Seyschab, G Bretzel, R Friedl, D Schindler, Y Sun, H Hoehn. Modulation of the spontaneous G2 phase blockage in Fanconi anemia cells by caffeine: differences to cells arrested by X-irradiation. Mutat Res 308:149-157, 1994.
113. P Johnstone, C Reifsteck, S Kohler, P Worland, S Olson, RE Moses. Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation. Somat Cell Mol Genet 23:371-377, 1997.
114. MC Heinrich, ME Hoatlin, AJ Zigler, KV Silvey, AC Bakke, WW Keeble, Y Zhi, CA Reifsteck, M Grompe, MG Brown, RE Magenis, SB Olson, GC Bagby. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood 91:275-287, 1998.
115. GM Martin, SN Austad, TE Johnson. Genetic analysis of ageing: role of oxidative damage and environmental stresses. Nat Genet 13:25-34, 1996.
116. R Perez-Campo, M Lopes-Torres, S Cadenas, C Rojas, G Barja. The rate of free radical production as a determinant of the rate of aging: evidence from the comparative approach. J Comp Physiol (B) 168:149-158, 1998.
117. A Herrero, G Barja. 8-oxo-deoxyguanosine levels in heart and brain mitochondrial and nuclear DNA of two mammals and three birds in relation to their different rates of aging. Aging (Milano) 11:294-300, 1999.
118. H Joenje, F Arwert, AW Eriksson, H de Koning, AB Oostra. Oxygen-dependence of chromosomal aberrations in Fanconi's anemia. Nature 290:142-143, 1981.
119. D Schindler, H Hoehn. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet 43:429-435, 1988.
120. H Saito, AT Hammond, RE Moses. Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. Mutat Res 294:255-262, 1993.
121. H Saito, AT Hammond, RE Moses. The effect of low oxygen tension on the in vitro replicative lifespan of human diploid fibroblast cells and their transformed derivatives. Exp Cell Res 217:272-279, 1995.
122. M Poot, O Gross, B Epe, M Pflaum, H Hoehn. Cell cycle defect in connection with oxygen and iron sensitivity in Fanconi anemia lymphoblastoid cells. Exp Cell Res 222:262-268, 1996
123. H Maeda, T Hotta, H Yamada. Enhanced colony formation of human hematopoietic stem cells in reduced oxygen tension. Exp Hematol 14:930-934, 1986.
124. AP Alter, ME Knobloch, RS Weinberg. Erythropoiesis in Fanconi's anemia. Blood 78:602-608, 1991.
125. G Pagano, LG Korkina. Prospects for nutritional intervention in the clinical management of Fanconi anemia. Cancer Causes Control 11:881-889, 2000.
126. G Pagano, LG Korkina, P Degan, D Del Principe, B Lindau-Shepard, A Zatterale, C Franceschi. In vitro hypersensitivity to oxygen of Fanconi anemia (FA) cells is linked to ex vivo evidence for oxidative stress in FA homozygotes and heterozygotes. Blood 89:1111-1112, 1997.
127. W Ruppitsch, C Meisslitzer, M Hirsch-Kauffmann, M Schweiger. Overexpression of thioredoxin in Fanconi anemia fibroblasts prevents the cytotoxic and DNA damaging effect of mitomycin C and diepoxybutane. FEBS Lett 422:99-102, 1998.
128. D Lackinger, W Ruppitsch, MH Ramirez, M Hirsch-Kauffmann, M Schweiger. Involvement of the Fanconi anemia protein FA-C in repair processes of oxidative DNA damages. FEBS Lett 440:103-106, 1998.
129. W Liebetrau, TM Runger, BE Mehling, M Poot, H Hoehn. Mutagenic activity of ambient oxygen and mitomycin C in Fanconi's anaemia cells. Mutagenesis 12: 69-77, 1997.
130. MR Kelley, R Tritt, Y Xu, S New, B Freie, DW Clapp, WA Deutsch. The Drosophila S3 multifunctional DNA repair/ribosomal protein protects Fanconi anemia cells against oxidative DNA damaging agents. Mutat Res 485:107-119, 2001.
131. J Pincheira, M Bravo, MJ Santos, C de la Torre, JF Lopez-Saez. Fanconi anemia lymphocytes: effect of DL-alpha-tocopherol (vitamin E) on chromatid breaks and on G2 repair efficiency. Mutat Res 461:265-271, 2001.
132. DT Bowen. Oxidative stress and the myelodysplastic syndromes. Leuk Res 24:139-140, 2000.
133. R Notaro, N Montuori, C di Grazia, S Formisano, B Rotoli, C Selleri. Fanconi's anemia cells are relatively resistant to H2O2-induced damage. Haematologica 83:868-874, 1998.
134. AA Clarke, NJ Philpott, EC Gordon-Smith, TR Rutherford. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking. Br J Haematol 96:240-247, 1997.
135. G Pagano. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi’s anaemia phenotype. Carcinogenesis 21:1067-1068, 2000.
136. P Degan, S Bonassi, M De Caterina, LG Korkina, L Pinto, F Scopacasa, A Zatterale, R Calzone, G Pagano. In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi’s anaemia families. Carcinogenesis 16:735-741, 1995.
137. A Zunino, P Degan, T Vigo, A Abbondandolo. Hydrogen peroxide: effects on DNA, chromosomes, cell cycle and apoptosis induction in Fanconi’s anemia cell lines. Mutagenesis 16:283-238, 2001.
138. O Will, D Schindler, S Boiteux, B Epe. Fanconi’s anaemia cells have normal steady-state levels and repair of oxidative DNA base modifications sensitive to Fpg protein. Mutat Res 409:65-72, 1998.
139. 2 as determined by alkaline elution. Biochem Biophys Acta 698:237-242, 1982.
140. H Joenje, H Youssoufian, FA Kruyt, CC dos Santos, R Wevrick, M Buchwald. Expression of the Fanconi anemia gene FAC in human cell lines: lack of effect of oxygen tension. Blood Cells Mol Dis 21:182-191, 1995.
141. PA Tower, TA Christianson, ST Peters, ML Ostroski, ME Hoatlin, AJ Zigler, MC Heinrich, RK Rathbun, W Keeble, GR Faulkner, GC Bagby Jr. Expression of the Fanconi anemia group C gene in hematopoietic cells is not influenced by oxidative stress, cross-linking agents, radiation, heat, or mitotic inhibitory factors. Exp Hematol 26:19-26, 1998.
142. Y Wang, D Cortez, P Yazdi, N Neff, SJ Elledge, J Qin. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14:927-939, 2000.
143. F Le Page, V Randrianarison, D Marot, J Cabannes, M Perricaudet, J Feunteun, A Sarasin. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Cancer Res 60:5548-5552, 2000.
144. LC Gowen, AV Avrutskaya, AM Latour, BH Koller, SA Leadon. BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281:1009-1012, 1998.
145. JJP Gille, HM Wortelboer, H Joenje. Antioxidant status of Fanconi anemia fibroblasts. Hum Genet 77:28-31, 1987.
146. S Hadjur, K Ung, L Wadsworth, J Dimmick, E Rajcan-Separovic, RW Scott, M Buchwald, FR Jirik. Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismu-tase. Blood 98:1003-1011, 2001.
147. E Gluckman. Allogeneic bone marrow transplantation in Fanconi anemia. Bone Marrow Transplant Suppl 3:833-835, 1996.
148. FJ Millen, MG Rainey, JM Hows, PA Burton, GH Irvine, D Swirsky. Oral squamous cell carcinoma after allogeneic bone marrow transplantation for Fanconi anaemia. Br J Haematol 99:410-414, 1997.
149. M Aker, G Varadi, S Slavin, A Nagler. Fludarabine-based protocol for human umbilical cord blood transplantation in children with Fanconi anemia. J Pediatr Hema-tol Oncol 21:237-239, 1999.
150. F Boulad, A Gillio, TN Small, D George, V Prasad, J Torok-Castanza, AD Regan, N Collins, AD Auerbach, NA Kernan, RJ O’Reilly. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol 111:1153-1157, 2000.
151. D Josefson. Couple select healthy embryo to provide stem cells for sister. BMJ 321:917, 2000.
152. AD Auerbach, M Buchwald, H Joenje. Fanconi anemia. In: The Metabolic and Molecular Basis of Inherited Disease. CR Scriver, A Beaudet, W Sly, D Valle, B Childs, K Kinzler, B Vogelstein, eds. New York: McGraw-Hill, 2000, pp 753-768.
153. JM Liu, S Kim, EJ Read, M Futaki, I Dokal, CS Carter, SF Leitman, M Pensiero, NS Young, CE Walsh. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther 10:2337-2346, 1999.
154. H Youssoufian, FAE Kruyt, X Li. Protein replacement by receptor-mediated endo-cytosis corrects the sensitivity of Fanconi anemia group C cells to mitomycin C. Blood 93:363-369, 1999.
155. Y Takihara, J Hara. Polycomb-group genes and hematopoiesis. J Hematol 72:165-172, 2000.
156. GM Martin. Proliferative homeostasis and its age-related aberrations. Mech Ageing Dev 9:385-391, 1979.
157. NG Howlett, T Taniguchi, S Olson, B Cox, Q Waisfisz, C de Die-Smulders, N Persky, M Grompe, H Joenje, G Pals, H Ikeda, EA Fox, AD D’Andrea. Biallelic Inactivation of BRCA2 in Fanconi Anemia. Science, 297:606-609, 2002.
158. M Escarcellar, S Rousset, D Papadopolou. The fidelity of double strand break processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome. Somat Cell Mol Genet 23:401-11, 1997
159. T Taniguchi, I Garcia-Higuera, B Xu, PR Andreassen, RC Gregory, ST Kim, WS Lane, MB Kastan, AD D’Andrea. Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways. Cell 109:459-72, 2002
160. SI Ahmad, F Hanaoka, SH Kirk. Molecular biology of Fanconi anaemia—an old problem, a new sight. BioEssays 24:439-48, 2002
161. P Pace, M Johnson, WM Tan, G Mosedale, C Sng, M Hoatlin, J de Winter, H Joenje, F Gergely, KJ Patel. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J 21:3414-23, 2002